Tasaka K - Search Results

1

TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.

Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A. Ando T, et al. Among authors: tasaka k. Arthritis Res Ther. 2006;8(5):R146. doi: 10.1186/ar2038. Arthritis Res Ther. 2006. PMID: 16945157 Free PMC article.

2

TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.

Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A. Xu H, et al. Among authors: tasaka k. Biochem Biophys Res Commun. 2004 May 28;318(2):422-7. doi: 10.1016/j.bbrc.2004.04.036. Biochem Biophys Res Commun. 2004. PMID: 15120617

3

Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.

Ando T, Ichikawa J, Okamoto A, Tasaka K, Nakao A, Hamada Y. Ando T, et al. Among authors: tasaka k. J Orthop Res. 2005 Jul;23(4):964-9. doi: 10.1016/j.orthres.2005.01.010. Epub 2005 Apr 9. J Orthop Res. 2005. PMID: 16023013 Free article.

4

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.

Arizono Y, Yoshikawa H, Naganuma H, Hamada Y, Nakajima Y, Tasaka K. Arizono Y, et al. Among authors: tasaka k. Br J Cancer. 2003 Jan 27;88(2):298-306. doi: 10.1038/sj.bjc.6600666. Br J Cancer. 2003. PMID: 12610517 Free PMC article.

5

Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.

Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y, Tasaka K. Kinoshita H, et al. Among authors: tasaka k. Int J Cancer. 2000 Dec 15;88(6):986-91. doi: 10.1002/1097-0215(20001215)88:6<986::aid-ijc23>3.0.co;2-b. Int J Cancer. 2000. PMID: 11093825

6

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.

Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N, Tasaka K. Seki K, et al. Among authors: tasaka k. Cancer Chemother Pharmacol. 2000;45(3):199-206. doi: 10.1007/s002800050030. Cancer Chemother Pharmacol. 2000. PMID: 10663637

7

Serum IgG from CBA/K1Jms-lprcg/lprcg mice induces interleukin 3 in an interleukin-3-dependent cell line--possible correlation with lymphadenopathy.

Sato E, Iwamoto M, Sakihama T, Yokoyama Y, Hamada Y, Matsuzawa A, Akamatsu N, Nakajima Y, Tasaka K. Sato E, et al. Among authors: tasaka k. Cell Immunol. 1991 Dec;138(2):372-80. doi: 10.1016/0008-8749(91)90161-4. Cell Immunol. 1991. PMID: 1934077

8

Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation.

Shiiki K, Yoshikawa H, Kinoshita H, Takeda M, Ueno A, Nakajima Y, Tasaka K. Shiiki K, et al. Among authors: tasaka k. Cell Death Differ. 2000 Oct;7(10):939-46. doi: 10.1038/sj.cdd.4400727. Cell Death Differ. 2000. PMID: 11279540

9

Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.

Kawataki T, Naganuma H, Sasaki A, Yoshikawa H, Tasaka K, Nukui H. Kawataki T, et al. Among authors: tasaka k. Neuropathology. 2000 Sep;20(3):161-9. doi: 10.1046/j.1440-1789.2000.00327.x. Neuropathology. 2000. PMID: 11132930

10

Fc gammaRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1).

Yoshikawa H, Sakihama T, Nakajima Y, Tasaka K. Yoshikawa H, et al. Among authors: tasaka k. Blood. 1997 Sep 1;90(5):1911-9. Blood. 1997. PMID: 9292524 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters